• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.

作者信息

Yang Xi, Zhou Tian, Ji Tong, Jia Hao, Liu Wei

机构信息

Department of Oral and Maxillofacial Surgery, Zhang Zhiyuan Academician Workstation, Hainan Western Central Hospital, Shanghai Ninth People's Hospital, Danzhou, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China; Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China; Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Oral Oncol. 2022 Jul;130:105901. doi: 10.1016/j.oraloncology.2022.105901. Epub 2022 May 6.

DOI:10.1016/j.oraloncology.2022.105901
PMID:35533509
Abstract
摘要

相似文献

1
Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.关于循环微小RNA作为口腔潜在恶性疾病和口腔鳞状细胞癌治疗分子的评论。
Oral Oncol. 2022 Jul;130:105901. doi: 10.1016/j.oraloncology.2022.105901. Epub 2022 May 6.
2
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.关于口腔肿瘤学中致编辑信的评论，这些信将微小RNA作为口腔鳞状细胞癌的治疗分子。
Oral Oncol. 2023 Feb;137:106298. doi: 10.1016/j.oraloncology.2022.106298. Epub 2022 Dec 28.
3
Authors reply to the comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.作者回复关于口腔肿瘤学中致编辑信函的评论，该评论将微小RNA视为口腔鳞状细胞癌的治疗分子。
Oral Oncol. 2023 Feb;137:106306. doi: 10.1016/j.oraloncology.2023.106306. Epub 2023 Jan 7.
4
Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).循环微小RNA抑制及其信号通路在口腔鳞状细胞癌（OSCC）治疗中的作用
Oral Oncol. 2022 Mar;126:105763. doi: 10.1016/j.oraloncology.2022.105763. Epub 2022 Feb 7.
5
MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.微小RNA-31作为口腔鳞状细胞癌的潜在治疗生物标志物：当前证据与未来展望
Exp Oncol. 2022 Nov;44(3):263-264. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-3.18569.
6
MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.miRNAs 作为口腔鳞状细胞癌 (OSCC) 和口腔潜在恶性疾病 (OPMD) 患者血清中的非侵入性生物标志物。
Arch Oral Biol. 2023 Mar;147:105627. doi: 10.1016/j.archoralbio.2023.105627. Epub 2023 Jan 16.
7
Resveratrol and miR-200c: insights into the prevention of oral squamous cell carcinoma.白藜芦醇与miR-200c：对口腔鳞状细胞癌预防的见解
Future Oncol. 2022 Oct;18(31):3471-3472. doi: 10.2217/fon-2022-0672. Epub 2022 Oct 21.
8
MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.微小RNA-138及其靶点：一种用于口腔鳞状细胞癌的治疗分子。
Oral Oncol. 2022 Jul;130:105925. doi: 10.1016/j.oraloncology.2022.105925. Epub 2022 May 21.
9
Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.口腔鳞状细胞癌中miR-21、miR-125b-2*、miR-138、miR-155、miR-184和miR-205水平的改变及其与临床病理特征的关联
J Oral Pathol Med. 2015 Nov;44(10):792-800. doi: 10.1111/jop.12300. Epub 2014 Dec 8.
10
Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.循环微小RNA作为口腔鳞状细胞癌手术患者复发的生物标志物
Oncotarget. 2017 Jan 31;8(5):8206-8214. doi: 10.18632/oncotarget.14143.

引用本文的文献

1
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy.循环微RNA作为口腔癌液体活检中的生物标志物
Biomedicines. 2023 Mar 21;11(3):965. doi: 10.3390/biomedicines11030965.